Osaic Holdings’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
35,950
-3,931
-10% -$105K ﹤0.01% 2625
2025
Q4
$1.15M Buy
39,881
+6,722
+20% +$87.8K ﹤0.01% 2558
2025
Q3
$215K Buy
33,159
+14,687
+80% +$108K ﹤0.01% 4148
2025
Q2
$183K Buy
18,472
+1,621
+10% +$17.1K ﹤0.01% 4016
2025
Q1
$160K Buy
16,851
+6,296
+60% +$87.4K ﹤0.01% 3817
2024
Q4
$146K Sell
10,555
-230,195
-96% -$4.03M ﹤0.01% 3884
2024
Q3
$3.66M Buy
240,750
+78,450
+48% +$388K 0.01% 1260
2024
Q2
$774K Buy
162,300
+4,100
+3% +$22.9K ﹤0.01% 2398
2024
Q1
$1.07M Buy
158,200
+41,650
+36% +$201K ﹤0.01% 2266
2023
Q4
$570K Buy
116,550
+110,550
+1,843% +$360K ﹤0.01% 3044
2023
Q3
$20.5K Hold
6,000
﹤0.01% 5543
2023
Q2
$28.7K Buy
6,000
+1,000
+20% +$4.39K ﹤0.01% 5317
2023
Q1
$21.1K Hold
5,000
﹤0.01% 5549
2022
Q4
$19K Hold
5,000
﹤0.01% 5597
2022
Q3
$30K Hold
5,000
﹤0.01% 5291
2022
Q2
$17K Hold
5,000
﹤0.01% 5713
2022
Q1
$17K Hold
5,000
﹤0.01% 5795
2021
Q4
$15K Hold
5,000
﹤0.01% 5973
2021
Q3
$20K Buy
+5,000
New +$22.8K ﹤0.01% 5763

Other funds holding CAPR

Osaic Holdings's CAPR Position: Q1 2026 in Review

Osaic Holdings reduced its Capricor Therapeutics (CAPR) stake by 9.9% in Q1 2026, selling an estimated $105K and leaving 35,950 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

Osaic Holdings first reported a position in CAPR in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.66M in Q3 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Osaic Holdings held 35,950 shares of Capricor Therapeutics worth $1.09M as of Q1 2026.
  • Osaic Holdings sold 3,931 Capricor Therapeutics shares in Q1 2026, an estimated $105K.
  • Capricor Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2625 holding.
  • Osaic Holdings first reported a position in Capricor Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Capricor Therapeutics position peaked at $3.66M in Q3 2024.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.